Evidence map›Paper›PMID 32468493›Full record

ArticleCurrent topics in behavioral neurosciences2020

Nicotinic Receptors Underlying Nicotine Dependence: Evidence from Transgenic Mouse Models.

Cassandra D Gipson, Christie D Fowler

Open access · greenAbstract read
In one paragraph

Article in Current topics in behavioral neurosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Drug Discovery Targeting Nicotinic Acetylcholine Receptors for Hearing Loss.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Nicotinic receptors in airway disease.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  8. Review
  9. Review
  10. Tobacco and nicotine use.Nature reviews. Disease primers · 2022
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Cassandra D GipsonDepartment of Family and Community Medicine, University of Kentucky, Lexington, KY, USA.
Christie D FowlerDepartment of Neurobiology and Behavior, University of California, Irvine, CA, USA. cdfowler@uci.edu.
University of California, Irvine · USUniversity of Kentucky · US

Funding

Circulating miRNAs and Epigenetic Regulation in Nicotine AddictionDP1DA039658 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI FOWLER, CHRISTIE D · 2015 to 2019
$2.3M
Cholinergic modulation of glutamatergic signaling in nicotine addiction and relapseR21DA044479 · NIDA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI GIPSON-REICHARDT, CASSANDRA D, OLIVE, M. FOSTER · 2018 to 2019
$461k
Glutamatergic mechanisms underlying nicotine addiction and relapse following nicotine reductionR03DA045881 · NIDA · UNIVERSITY OF KENTUCKY · PI GIPSON-REICHARDT, CASSANDRA D · 2018 to 2019
$154k
NIDA NIH HHS DP1 DA039658NIDA NIH HHS R03 DA045881NIDA NIH HHS R21 DA044479
6 · The paper itself

Abstract

Nicotine underlies the reinforcing properties of tobacco cigarettes and e-cigarettes. After inhalation and absorption, nicotine binds to various nicotinic acetylcholine receptor (nAChR) subtypes localized on the pre- and postsynaptic membranes of cells, which subsequently leads to the modulation of cellular function and neurotransmitter signaling. In this chapter, we begin by briefly reviewing the current understanding of nicotine's actions on nAChRs and highlight considerations regarding nAChR subtype localization and pharmacodynamics. Thereafter, we discuss the seminal discoveries derived from genetically modified mouse models, which have greatly contributed to our understanding of nicotine's effects on the reward-related mesolimbic pathway and the aversion-related habenulo-interpeduncular pathway. Thereafter, emerging areas of research focusing on modulation of nAChR expression and/or function are considered. Taken together, these discoveries have provided a foundational understanding of various genetic, neurobiological, and behavioral factors underlying the motivation to use nicotine and related dependence processes, which are thereby advancing drug discovery efforts to promote long-term abstinence.

Indexed as

Electronic Nicotine Delivery SystemsReceptors, NicotinicTobacco Use DisorderAnimalsMiceMice, TransgenicNicotineNicotineReceptors, NicotinicAddictionBraine-cigaretteNicotineNicotinic acetylcholine receptors (nAChRs)Tobacco cigarette

Identifiers

PMID32468493
PMCPMC8442880
OpenAlexW3032846442

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.